Northcape Capital’s Fleur Wright may have missed out in the early AI and GLP-1 investor frenzy, but she made other good calls ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to ...

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

Here is our list of the 15 unhealthiest countries in Europe. Insider Monkey Score: 14.5 ...

Researchers attempt to identify 15 Medicare Part D drugs with the highest risk of facing the U.S. government's ...

People who take Novo Nordisk's semaglutide-based injectables Ozempic and Wegovy seem to be way less likely to die from ...

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top ...

In this Saturday version of Insider Today, we're talking about Austin, Texas' real estate cycle and the price of weight-loss ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

European stocks face a series of hurdles to extend their 2024 rally after hitting another record high this week.